Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Vitrafy Life Sciences Ltd. ( (AU:VFY) ).
Vitrafy Life Sciences Limited has announced the appointment of Leigh Farrell as a new director, effective from October 16, 2025. The initial director’s interest notice indicates that Leigh Farrell currently holds no relevant interests in securities, either as a registered holder or otherwise, and has no interests in contracts related to the company. This appointment is a procedural update and does not immediately impact the company’s operations or market positioning.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Average Trading Volume: 14,817
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$80.77M
Find detailed analytics on VFY stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “More Hopeful than Real”: Is a Bidding War Brewing for Warner Bros. Discovery Stock (NASDAQ:WBD)?
- “Didn’t Develop the Way Automakers Thought.” Ford Notches Up, Reconsidering the EV Market
- “Our Focus is Increasingly…on Inference”: Intel Stock (NASDAQ:INTC) Jumps With Crescent Island Testing Next Year